Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Extends Tender Offer for Iris

NEW YORK (GenomeWeb News) – Danaher today said it is extending its tender offer for Iris International to midnight EDT, Oct. 29 in order to allow investors time to consider new disclosures by Iris.

The tender offer previously was scheduled to expire at midnight EDT, Oct. 18. Danaher announced its plans to acquire Iris last month for $338 million.

In a document filed with the US Securities and Exchange Commission today, Iris disclosed new financial projections for 2012 to 2020.

Danaher said that the depositary for the tender offer has told it that as of 4:30 PM Oct. 16, Iris shareholders had validly tendered about 5.8 million shares of the company's stock, or about 31 percent of Iris shares outstanding.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.